KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Treasury Shares (2016 - 2025)

Edwards Lifesciences has reported Treasury Shares over the past 17 years, most recently at $7.1 billion for Q4 2025.

  • Quarterly results put Treasury Shares at $7.1 billion for Q4 2025, up 14.52% from a year ago — trailing twelve months through Dec 2025 was $7.1 billion (up 14.52% YoY), and the annual figure for FY2025 was $7.1 billion, up 14.52%.
  • Treasury Shares for Q4 2025 was $78.0 million at Edwards Lifesciences, up from $6.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for EW hit a ceiling of $78.0 million in Q4 2025 and a floor of $1.1 million in Q3 2022.
  • Median Treasury Shares over the past 5 years was $31.6 million (2022), compared with a mean of $34.2 million.
  • Biggest five-year swings in Treasury Shares: soared 71.46% in 2022 and later increased 14.37% in 2024.
  • Edwards Lifesciences' Treasury Shares stood at $2.4 billion in 2021, then soared by 71.46% to $4.1 billion in 2022, then increased by 21.25% to $5.0 billion in 2023, then increased by 23.24% to $6.2 billion in 2024, then grew by 14.52% to $7.1 billion in 2025.
  • The last three reported values for Treasury Shares were $7.1 billion (Q4 2025), $7.0 billion (Q3 2025), and $6.5 billion (Q2 2025) per Business Quant data.